VanEck Pharmaceutical ETF PPH
Set alert
119.33 USD +2.41 +2.06%
At close · Oct 30
119.94 +0.61 +0.51%
After hours · Oct 30, 6:49 PM ET
118.97 Day range 120.86
92.35 52-week range 119.33
- YTD
- +15.66%
- 1 year
- +29.21%
- Open
- 119.73
- Prev close
- 116.92
- Mkt cap
- 1.07B
- Vol
- 1.28M
- Avg vol
- 306.18K
- EPS
- 4.37
- P/E
- 27.28
- Div yield
- 0.00%
More statistics
- Low
- 118.97
- High
- 120.86
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 112.51
- 200-d avg
- 107.85
5Y chart
Events in this range
- Dec 29, 2021Dividend: 0.269
- Apr 1, 2022Dividend: 0.443
- Jul 1, 2022Dividend: 0.25
- Oct 3, 2022Dividend: 0.27
- Dec 28, 2022Dividend: 0.24
- Dec 30, 2022Dividend: 0.24
- Apr 3, 2023Dividend: 0.6641
- Jul 3, 2023Dividend: 0.3891
- Oct 2, 2023Dividend: 0.3398
- Dec 27, 2023Dividend: 0.3074
- Apr 1, 2024Dividend: 0.5328
- Jul 1, 2024Dividend: 0.3558
- Oct 1, 2024Dividend: 0.409
- Dec 27, 2024Dividend: 0.411
- Apr 1, 2025Dividend: 0.5245
- Jul 1, 2025Dividend: 0.6069
- Oct 1, 2025Dividend: 0.3931
- Dec 29, 2025Dividend: 0.3106
- Apr 1, 2026Dividend: 0.8441
- Jul 1, 2026Dividend: 0.6248
- Oct 1, 2026Dividend: 0.36
Signals (98)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 28, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 23, 2024 | 2 years ago |
| RSI: Overbought | Aug 12, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 8, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| RSI: Overbought | Mar 25, 2024 | 2 years ago |
| RSI: Overbought | Feb 12, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 18, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Oct 16, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| MACD: Sell Signal | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 10, 2023 | 3 years ago |
| SMA: Bullish | Mar 27, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Jan 23, 2023 | 3 years ago |
| SMA: Bullish | Nov 21, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bearish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bearish | May 30, 2022 | 4 years ago |
| SMA: Bullish | May 23, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| SMA: Bearish | Feb 28, 2022 | 4 years ago |
| SMA: Bullish | Feb 21, 2022 | 4 years ago |
| SMA: Bearish | Feb 14, 2022 | 4 years ago |
| SMA: Bullish | Jan 24, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.28
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 112.51
- 200-day average
- 107.85
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
- Execution of Pharma Tariffs Brings These ETFs Into Focus
- Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
- Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
- VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
- Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
- Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.